PDS Biotechnology
PDSB
PDSB
31 hedge funds and large institutions have $2.83M invested in PDS Biotechnology in 2018 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
65% less capital invested
Capital invested by funds: $8.01M → $2.83M (-$5.18M)
Holders
31
Holding in Top 10
–
Calls
$15K
Puts
–
Top Buyers
| 1 | +$96.6K | |
| 2 | +$78K | |
| 3 | +$32K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$25.9K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$19K |
Top Sellers
| 1 | -$820K | |
| 2 | -$164K | |
| 3 | -$88K | |
| 4 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
-$64K |
| 5 |
Millennium Management
New York
|
-$52K |